Inoges S - Search Results

1

Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.

Redondo P, del Olmo J, López-Diaz de Cerio A, Inoges S, Marquina M, Melero I, Bendandi M. Redondo P, et al. Among authors: inoges s. J Invest Dermatol. 2007 Jul;127(7):1673-80. doi: 10.1038/sj.jid.5700777. Epub 2007 Mar 22. J Invest Dermatol. 2007. PMID: 17380112 Free article.

2

Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers.

Bendandi M, Tonelli R, Maffei R, Botti S, Turi C, Sartini R, Inogés S, Calvillo MR, Zinzani PL, Pession A, Pileri SA, Paolucci G. Bendandi M, et al. Among authors: inoges s. Ann Oncol. 2001 Oct;12(10):1479-84. doi: 10.1023/a:1012586905273. Ann Oncol. 2001. PMID: 11762822 Free article.

3

Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.

Arina A, Tirapu I, Alfaro C, Rodríguez-Calvillo M, Mazzolini G, Inogés S, López A, Feijoo E, Bendandi M, Melero I. Arina A, et al. Among authors: inoges s. Exp Hematol. 2002 Dec;30(12):1355-64. doi: 10.1016/s0301-472x(02)00956-6. Exp Hematol. 2002. PMID: 12482496 Free article. Review.

4

Feasibility of idiotype vaccination in relapsed B-cell malignancies.

Inogés S, Rodríguez-Calvillo M, López-Díaz de Cerio A, Zabalegui N, Pérez-Calvo J, Panizo C, Hernandez M, Cuesta B, Rocha E, Bendandi M. Inogés S, et al. Haematologica. 2003 Dec;88(12):1438-40. Haematologica. 2003. PMID: 14688006 No abstract available.

5

Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.

Zabalegui N, de Cerio AL, Inogés S, Rodríguez-Calvillo M, Pérez-Calvo J, Hernández M, García-Foncillas J, Martín-Algarra S, Rocha E, Bendandi M. Zabalegui N, et al. Among authors: inoges s. Haematologica. 2004 May;89(5):541-6. Haematologica. 2004. PMID: 15136216

6

[Active immunotherapy in the treatment of haematological neoplasias].

Inogés S, Rodríguez Calvillo M, López Díaz de Cerio A, Zabalegui N, Melero I, Sánchez Ibarrola A, Rocha E, Bendandi M. Inogés S, et al. An Sist Sanit Navar. 2004 Jan-Apr;27(1):45-62. doi: 10.4321/s1137-66272004000100006. An Sist Sanit Navar. 2004. PMID: 15146205 Free article. Review. Spanish.

7

Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development.

Rodríguez-Calvillo M, Inogés S, López-Díaz de Cerio A, Zabalegui N, Villanueva H, Bendandi M. Rodríguez-Calvillo M, et al. Among authors: inoges s. Crit Rev Oncol Hematol. 2004 Oct;52(1):1-7. doi: 10.1016/j.critrevonc.2004.05.002. Crit Rev Oncol Hematol. 2004. PMID: 15363462 Review.

8

Imatinib mesylate in cutaneous melanoma.

Redondo P, Lloret P, Andreu EJ, Inoges S. Redondo P, et al. Among authors: inoges s. J Invest Dermatol. 2004 Dec;123(6):1208-9. doi: 10.1111/j.0022-202X.2004.23496.x. J Invest Dermatol. 2004. PMID: 15610538 Free article. No abstract available.

9

[Past, present and future of anti-idiotype vaccination].

Rodríguez Calvillo M, Inogés S, López Díaz de Cerio A, Zabalegui N, Panizo C, Hernández M, Pérez Calvo J, Prósper F, Melero I, Sánchez-Ibarrola A, Rocha E, Bendandi M. Rodríguez Calvillo M, et al. Among authors: inoges s. Rev Med Univ Navarra. 2004 Jul-Sep;48(3):14-23. Rev Med Univ Navarra. 2004. PMID: 15622921 Review. Spanish.

10

Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.

Redondo P, Lloret P, Idoate M, Inoges S. Redondo P, et al. Among authors: inoges s. Clin Exp Dermatol. 2005 Sep;30(5):541-5. doi: 10.1111/j.1365-2230.2005.01849.x. Clin Exp Dermatol. 2005. PMID: 16045689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page